The prevalence of diabetes and diabetic nephropathy is increasing, especially in middle eastern countries. Many patients reach end-stage renal disease and either start dialysis or consider preemptive transplantation. Even a higher number of patients develop post-transplant diabetes, which imposes an even higher risk on graft survival and outcomes post-transplantation. Recently, in the UAE, a renal transplant service has been initiated. Because the population is considered at high risk for post-transplant diabetes, we wrote this review article to discuss the prevalence, risk factors, diagnostic criteria, and management, including lifestyle interventions, manipulation of immunosuppressant agents, and suggested algorithms for the use of oral hypoglycemic agents used in the management of post-transplantation diabetes mellitus. We also discussed the specific indications for each of the oral hypoglycemic agents.
Dubai Diabetes Endocrinol J 2022;28:79–92

中文翻译：

---

移植后糖尿病：患病率、风险和管理挑战

糖尿病和糖尿病肾病的患病率正在增加，尤其是在中东国家。许多患者达到终末期肾病并开始透析或考虑抢先移植。甚至更多的患者发展为移植后糖尿病，这对移植物存活和移植后结果施加了更高的风险。最近，在阿联酋，一项肾移植服务已经启动。由于人群被认为是移植后糖尿病的高危人群，我们撰写这篇评论文章来讨论患病率、风险因素、诊断标准和管理，包括生活方式干预、免疫抑制剂的操作以及使用口服药物的建议算法用于治疗移植后糖尿病的降糖药。
迪拜糖尿病内分泌杂志 2022；28:79–92